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Summary 21 
Background: P. aeruginosa is a leading cause of healthcare-associated infections in 22 
the ICU. 23 
Aim: this study investigated an unexplained increase in the incidence of P. 24 
aeruginosa recovered from clinical samples in the ICU over a two-year period. 25 
Methods: after unsuccessful epidemiological investigation by conventional tools, P. 26 
aeruginosa clinical isolates of all patients hospitalized between January 2010 and 27 
July 2012 were typed by a novel double-locus sequence typing (DLST) method and 28 
compared to environmental isolates recovered during the investigation period. 29 
Findings: in total, 509 clinical isolates from 218 patients and 91 environmental 30 
isolates were typed. Thirty-five different genotypic clusters were found among 31 
154/218 patients (71%). The largest cluster, DLST 1-18, included 23 patients who 32 
were mostly hospitalized during overlapping periods in the burn unit. Genotype DLST 33 
1-18 was also recovered from floor traps, shower trolleys and the shower mattress in 34 
the hydrotherapy rooms, suggesting environmental contamination of the burn unit as 35 
the source of the outbreak. After implementation of appropriate infection control 36 
measures, this genotype was recovered only once in a clinical sample from a burned 37 
patient and twice in the environment, but never thereafter during a 12-month follow-38 
up period. 39 
Conclusion: the use of a novel DLST method allowed the genotyping of a large 40 
number of clinical and environmental isolates, leading to the identification of the 41 
environmental source of a large unrecognized outbreak in the burn unit. Eradication 42 
of the outbreak was confirmed after implementation of a continuous epidemiological 43 
surveillance of P. aeruginosa clones in the ICU. 44 
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 46 
Introduction 47 
Pseudomomas aeruginosa remains a leading cause of healthcare-associated 48 
infections in critically-ill patients, particularly ventilator-associated pneumonia and 49 
burn wound infection (1, 2). It is found in the digestive tract of 3-24% of hospitalized 50 
patients. The source of this opportunistic pathogen can be either endogenous or 51 
exogenous (3-6). 52 
Since 1998, our infection control team performs regular epidemiological surveillance 53 
of P. aeruginosa in the intensive care unit (ICU), based on molecular typing (5, 7). All 54 
clinical strains are stored at -80°C in the microbiology laboratory. Pulsed-field gel 55 
electrophoresis (PFGE) is generally considered the gold standard for local 56 
epidemiological studies because of its high discriminatory power. However, this 57 
method is labor intensive and shows low inter-laboratory reproducibility (8, 9), 58 
especially when large numbers of isolates are analyzed. In this context, we 59 
developed the double-locus sequence typing (DLST) method based on the 60 
sequencing of two highly variable loci ms172 and ms217 (10). The high typability, 61 
discriminatory power, and ease of use of the proposed DLST scheme make it a 62 
method of choice for local epidemiological analyses of P. aeruginosa (10). Moreover, 63 
the possibility to give unambiguous definition of types allows standardization 64 
(http://www.dlst.org) and integration of results into hospital laboratory informative 65 
systems which can then be used for surveillance. 66 
In our institution, incidence of P. aeruginosa in the ICU is prospectively monitored 67 
using an electronic alert system reporting any clinical sample growing P. aeruginosa 68 
in patients hospitalized in this unit. From 2009 onward, an unexplained 30% increase 69 
in the incidence of P. aeruginosa recovered from clinical samples was observed in 70 
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the ICU of our hospital, rising from 32.2 cases per 1000 admissions in 2009 to 41.5 in 71 
2010 and 44.7 in 2011. Unusual early-onset P. aeruginosa infections in these 72 
patients were also reported. After unsuccessful investigation with conventional 73 
epidemiological tools, the DLST method was implemented to investigate this increase 74 
and identify potential outbreaks due to a chain of transmission or a common 75 
reservoir. 76 
Methods 77 
Study setting 78 
Lausanne University Hospital is a 1000-bed tertiary-care centre with 32 adult ICU 79 
beds, including four burn ICU beds, one hydrotherapy room and one isolation room 80 
with full hydrotherapy and surgical equipment. Approximately 40 burned patients are 81 
hospitalized in this unit every year and 360 hydrotherapy treatments are performed. 82 
Hydrotherapy consists of showers with filtered tap water carried out on a trolley 83 
covered with a plastic mattress. According to burn extension, patients are showered 84 
one to three times a week. The hydrotherapy room is occasionally used for non-85 
burned patients, such as Lyell syndrome. There are no automatic taps in the burn 86 
unit. 87 
Clinical isolates 88 
All consecutive patients hospitalized in the ICU with a clinical sample growing P. 89 
aeruginosa at any site between January 2010 and July 2012 were included. Based 90 
on colony morphology, one or several P. aeruginosa isolates per clinical sample were 91 
chosen for further typing analysis. For patients with prolonged ICU stays, multiple 92 
samples (one every two weeks until ICU discharge) were considered for isolates 93 
recovery. No routine screening of P. aeruginosa carriage was performed. The study 94 
was approved by local Ethics Committee: no consent was required. 95 
6 
 
Environmental isolates 96 
Between March 2012 and July 2012, tap water samples and environmental swabs 97 
obtained from taps and sink traps of all ICU rooms, as well as from the environment 98 
of the hydrotherapy rooms, including shower trolleys and shower mattresses, were 99 
analyzed. Swabs were inoculated on a cetrimide agar plate. Water samples were 100 
filtered on a 0.45 m membrane; which was deposited on a cetrimide agar plate. 101 
Plates were incubated 48h at 35°C. 102 
Genotyping method 103 
DLST was implemented in our institution for P. aeruginosa isolates genotyping in 104 
March 2012. The technique has been previously described (10). All environmental 105 
and clinical isolates from March 2012 onward were prospectively genotyped. Clinical 106 
strains before this date were unfrozen and analyzed retrospectively. 107 
Epidemiological definitions 108 
A case was defined as a patient hospitalized in the ICU and infected or colonized by 109 
a given genotype of P. aeruginosa. Cases sharing the same DLST genotype as other 110 
environmental or clinical isolates were defined as belonging to the same genotypic 111 
cluster. Epidemiological data (unit-s and room-s of hospitalization, dates of admission 112 
and discharge) and clinical data of patients belonging to the largest cluster were 113 
retrieved from the hospital information system and the medical charts. 114 
Results 115 
Clinical isolates genotyping 116 
During the study period, 246 patients with at least one clinical sample growing P. 117 
aeruginosa were hospitalized in the ICUs. For 19 patients (17 from 2010), no isolate 118 
was available for typing. Overall, 525 clinical isolates from 227 patients were 119 
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analyzed (median 1 isolate per patient, range 1-23), of which 509 from 218 patients 120 
were successfully genotyped (16 isolates in 9 patients were untypable for technical 121 
reasons). For 12 patients, two different genotypes were recovered in the same 122 
individual and for one, three distinct genotypes were found. A unique genotype, not 123 
recovered from other patients or the environment, was found in 64/218 (29%) 124 
patients, while 35 genotypic clusters were isolated in the remaining 154/218 (71%) 125 
patients (median 3 patients per cluster, range 2-23). The largest cluster included 23 126 
patients infected or colonized with the genotype DLST 1-18. This cluster was further 127 
investigated. 128 
Environmental isolates genotyping 129 
Between March 2012 and July 2012, 99 environmental isolates were recovered, 130 
mainly from sink traps. All water samples and swabs of taps were negative. Eight 131 
strains were untypable for technical reasons. Among the 91 isolates that could be 132 
analyzed, 24 different genotypes were found. DLST 1-18 was found in 14 isolates, of 133 
which 12 from samples collected in the hydrotherapy rooms, including floor traps, a 134 
plastic board under the shower mattress and a plastic rubber in a damaged corner of 135 
the mattress. One other DLST 1-18 isolate was recovered from the sink trap in the 136 
room of a burn patient and two from the sink trap of a single room in the neighboring 137 
ICU unit (Table 1). 138 
Epidemiological investigation of cluster DLST 1-18 139 
The 23 patients infected or colonized by P. aeruginosa DLST 1-18 were hospitalized 140 
between January 2010 and June 2012 mostly during overlapping periods. All patients 141 
but two were hospitalized either in the burn unit (18/23) or in the neighboring unit 142 
(3/23), of whom 19 were treated in the hydrotherapy room. The two other patients 143 
were a burned child hospitalized in the pediatric ICU who came frequently to the adult 144 
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hydrotherapy room and one patient (index case) hospitalized in a distant unit without 145 
geographical link with the rest of the cluster (Figure 1). The subjects contaminated 146 
with DLST 1-18 represented 19 % (18/95) of the total number of burned patients 147 
hospitalized in the burn unit between January 2010 and June 2012. Median time from 148 
ICU admission to recovery of first P. aeruginosa strain was 8.5 days (IQR: 4-15 149 
days). Five of 23 patients (22%) died and for two, multiresistant P. aeruginosa 150 
infection was the direct cause of death. Clinical characteristics of these 23 patients 151 
are shown in Table 2. 152 
Observations of practice standards and corrective measures 153 
Following the identification of the DLST 1-18 cluster in the burn unit, audits of 154 
infection control practices by a nurse trained in infection control were carried out. 155 
Several failures in good practice standards were observed during the disinfection 156 
procedures of shower trolleys and mattresses of the hydrotherapy rooms. 157 
Chlorexhidin-based disinfectant liquid soap solution was used to disinfect shower 158 
mattresses, although this antiseptic agent is inappropriate for inert surface cleansing. 159 
Shower trolleys were disinfected with a glucoprotamin-based solution without leaving 160 
enough time for this agent to act efficiently. The plastic board under the shower 161 
mattress remained wet until reuse for the next patient, thus allowing growth of P. 162 
aeruginosa in this moist environment, as confirmed by environmental sampling. 163 
Finally, damaged areas of shower mattresses had been repaired with rubber 164 
patches, which were shown to contain P. aeruginosa. Following these observations, 165 
corrective infection control measures were implemented, including i) revision of the 166 
disinfection protocol of the shower trolley and mattress, ii) drying of wet surfaces on 167 
shower mattress after disinfection, iii) replacement of all damaged shower 168 
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mattresses, and iv) reinforcement of disinfection of sink traps of all rooms of the burn 169 
unit by pouring daily one liter of bleach down all sinks.  170 
Follow-up screening 171 
During a whole year following the implementation of the new infection control 172 
standards in the burn unit, clinical isolates of all patients hospitalized in the ICU were 173 
collected and genotyped. Three-monthly routine environmental samples were 174 
implemented in all ICU rooms and recovered P. aeruginosa isolates genotyped as 175 
well. DLST 1-18 was found in a single patient three months after the implementation 176 
of control measures. The only link with the outbreak was the hospitalization of this 177 
case in the burn unit in a room occupied six months earlier by one of the 178 
contaminated patients (room 725, Table 1). While DLST 1-18 had not been found in 179 
this room previously, it was recovered in October 2012 and then in January 2013 in 180 
the sink trap. Thereafter, this genotype was never recovered in this room or in any 181 
other location of the ICU during the following 12 months. The incidence of P. 182 
aeruginosa recovered from clinical samples in the ICU decreased from 44.7 per 1000 183 
admissions in 2011 to 35.6 in 2012. 184 
Discussion 185 
We report an unrecognized two-year P. aeruginosa outbreak in a burn unit, 186 
uncovered after the implementation of a new DLST method. This fast and convenient 187 
technique, optimizing workflow by using 96-well plates, allowed retrospective and 188 
prospective genotyping of a large number of clinical and environmental isolates. This 189 
method gave unambiguous definitions of types facilitating comparison of strains and 190 
allowing the identification of this outbreak localized in the burn unit. In the follow-up 191 
period, it proved to be a useful tool to prospectively monitor all patients hospitalized 192 
in the ICU with clinical samples growing P. aeruginosa, thereby confirming the 193 
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complete eradication of the epidemic strain from hospitalized patients as well as from 194 
the environment of the burn unit. Next generation sequencing has emerged as the 195 
reference method and has been reported for epidemiological investigation of P. 196 
aeruginosa outbreaks, (11, 12). However, use of whole genome sequencing is 197 
currently limited to characterization of an outbreak strain and, unlike DLST, is not 198 
suitable for routine epidemiological surveillance. 199 
P. aeruginosa is a well-recognized cause of nosocomial infections among burned 200 
patients, classically appearing more than 14 days after admission (1, 13). The 201 
remarkable ability of this organism to survive on wet surfaces allows widespread 202 
contamination of hospital environment in damp areas, such as sinks, traps and 203 
hosing (14). Once established in these environmental niches, P. aeruginosa 204 
contamination can persist for months within a unit, thereby allowing continuous 205 
transmission to patients exposed to these areas. Indeed, several P. aeruginosa 206 
outbreaks have been reported in burn units, mostly through contamination of 207 
hydrotherapy equipment, such as showers and connecting tubes, but also through 208 
contamination of disinfectant solutions (15-18). Likewise, contamination of the 209 
hydrotherapy equipment by DLST 1-18 was the confirmed source of the present 210 
outbreak, as this clone was not recovered from any other locations of other intensive 211 
care units, except for the sink trap of a single room of the neighboring unit. 212 
Contamination of burned patients hospitalized during overlapping periods most likely 213 
occurred in the hydrotherapy room, which served as a reservoir allowing the 214 
persistence of the clone during periods when no colonized or infected patients were 215 
hospitalized in the unit. A strong case in favor of this hypothesis is patient 19, in 216 
whom skin biopsies taken in the hydrotherapy room on the day of admission grew P. 217 
aeruginosa. On the other hand, three patients infected with DLST 1-18 had no direct 218 
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contact with the burn unit or the hydrotherapy room. One patient was hospitalized in 219 
the neighboring unit at the same time and in a bed next to patient 11, suggesting 220 
patient-to-patient transmission. For two patients, no epidemiological link could be 221 
found, suggesting another unrecognized way of transmission.  222 
The persistent environmental transmission of DLST 1-18 could be successfully 223 
stopped after discovery of infection control failures and implementation of adequate 224 
corrective measures. Specifically, the avoidance of persistent wet surfaces, the 225 
appropriate use of disinfectants in the hydrotherapy room and the disinfection of sink 226 
traps yielded to the eradication of the epidemic strain DLST 1-18 from the 227 
environment. Indeed, except for a single case found in a patient hospitalized in a 228 
possibly contaminated room (positive sink trap), no further patient was contaminated 229 
with this strain after implementation of these corrective measures and follow-up 230 
environmental samplings showed complete disappearance of the strain during the 231 
following 12 months. 232 
This study has several limitations. No routine screening of P. aeruginosa colonization 233 
was performed in patients hospitalized in our ICU. As skin biopsies for 234 
microbiological cultures were sampled on a regular basis as a standard of care in all 235 
burned patients, it is unlikely that cases infected or colonized with DLST 1-18 would 236 
have been missed in these patients during the investigation period. In non-burned 237 
patients, occult respiratory or digestive P. aeruginosa colonization cannot be ruled 238 
out. However, as most patients staying in the ICU have microbiological samples 239 
drawn from clinically relevant sites during their stay, we believe that potential missed 240 
cases among non-burned patients contributed little, if any, to the dissemination of the 241 
epidemic strain. Another potential limitation was the fact that systematic 242 
environmental samples were not available before 2012, raising the hypothesis of 243 
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another site of P. aeruginosa contamination within the ICU between 2010 and 2012. 244 
However, the heavy contamination of the hydrotherapy room in 2012 and the fact 245 
that DLST 1-18 was mostly recovered in burned patients support a persistent 246 
contamination of the hydrotherapy equipment as the main source of the outbreak. 247 
Conclusions 248 
DLST is a new and attractive genotyping method which can be implemented for the 249 
prospective epidemiological surveillance of P. aeruginosa strains in the ICU. This 250 
convenient and straightforward tool may play an important role in future years in the 251 
early detection of otherwise unrecognized outbreaks in the ICU.  252 
253 
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Table 1. Molecular typing of environmental strains from rooms of unit 3 (burn unit) 332 
and 4 (neighboring unit) during initial investigation (2012) and follow-up period 333 
(2013). 334 
 March 2012 July 2012 November 2012 January 2013 March 2013 
Rooms Unit 3      
722 25-11 25-11 -  - 
723 - 6-7 / 8-37 -  - 
724 - - -  - 
725 1-21 - 1-18 1-18 / 1-21 25-11 
726* 1-18 6-7 26-46  - 
727 - - -  - 
728* 1-18 1-18 -  - 
Rooms Unit 4      
775 1-18 1-18 -  0-14 
780 18-34 18-34 0-14  0-14 / 48-40 
781 8-33 48-40 0-14  - 
782 20-30 / 48-40 20-30 / 48-40 20-30  18-34 
783 - - -  19-93 
 335 
* hydrotherapy rooms 336 
337 
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Table 2. Clinical characteristics and outcome of patients colonized or infected with P.aeruginosa genotype DLST 1-18 338 
Patient Sex, age 
Underlying 
condition 
Treated in the 
hydrotherapy 
room 
Time between 
ICU admission 
and first P. 
aeruginosa 
recovery (days) 
Site of P. aeruginosa 
infection or 
colonization 
Outcome  Cause of death 
1 F, 80 Heart failure No 15 urine survived - 
2 M, 81 Burn (13% BSA) Yes 2 wound survived - 
3 M, 50 Burn (38% BSA) Yes 9 wound , sputum survived - 
4 M, 27 Burn (22% BSA) Yes 10 blood, wound survived - 
5 F, 59 Necrotizing fasciitis Yes 15 wound survived - 
6 F, 20 Cystic fibrosis No 2* sputum, blood survived - 
7 F, 82 Burn (18% BSA) Yes 2 wound survived - 
8 M, 60 Burn (90% BSA) Yes 7 wound, sputum, blood died P. aeruginosa bacteremia 
9 M, 28 Burn (72% BSA) Yes 15 wound, sputum, blood survived - 
10 F, 38 Burn (15% BSA) Yes 14 wound survived - 
11 M, 81 Mediastinitis No 41 wound survived - 
12 F, 67 Pneumectomy No 34 sputum survived - 
13 M, 70 Burn (80% BSA) Yes 1 wound, sputum died C.albicans candidemia 
14 F, 3 Burn (20% BSA) Yes 5 urine, wound survived - 
15 M, 61 Burn (15% BSA) Yes 4 wound survived - 
16 M, 53 Burn (88% BSA) Yes 4 wound, sputum, blood died therapeutic withdrawal 
17 F, 58 Burn (60% BSA) Yes 34 wound, sputum, blood died P. aeruginosa bacteremia 
18 F, 44 Burn (40% BSA) Yes 15 wound, sputum, urine survived - 
19 F, 51 Burn (97% BSA) Yes 1 wound died refractory shock 
20 F, 51 Burn (25% BSA) Yes 21 wound survived - 
21 M, 33 Burn (30% BSA) Yes 7 wound, sputum, blood survived - 
22 M, 57 Sacral pressure ulcer Yes 8 wound, sputum survived - 
23 M, 38 Burn (60% BSA) Yes 7 wound, sputum survived - 
BSA : body surface area. 339 
*Already colonized with P. aeruginosa during previous hospital stays (no typisation of those strains were performed 340 
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 341 
Figure 1. Hospital stay of patients colonized or infected with the P. aeruginosa 342 
genotype DLST 1-18. Patients are numbered chronologically according to the time of 343 
first DLST 1-18 isolation. 344 
 345 
